Analysis of molecular mechanisms of chemoresistance in malignant glioma cells
Analysis of molecular mechanisms of chemoresistance in malignant glioma cells
批准号:
14370438
负责人:
SAYA Hideyuki
金额:
$9.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
细胞周期检查点防止从细胞周期的一个阶段过渡到下一个阶段,直到当前阶段的所有过程完成。检查点功能的缺陷导致基因突变和染色体损伤,从而促进肿瘤的发生和发展。然而,一些癌细胞中检查点功能的丧失被认为与它们对化疗和放疗等抗肿瘤治疗的敏感性有关。包括恶性胶质瘤在内的大多数癌细胞都缺乏G_1检查点功能,因此在暴露于基因毒性物质时不能在G_1期阻滞。相反,它们暂时聚集在G_2相。然而,考虑到G_2检查点在癌细胞中也部分受损,它们无法维持G_2阻滞,最终在进入有丝分裂时死亡。这个过程被称为有丝分裂灾难。诱导有丝分裂突变是癌症治疗的一个重要目标。在本项目中,我们描述了p53缺陷癌细胞中DNA损伤诱导的有丝分裂灾难的动力学。大多数细胞进入有丝分裂时DNA损伤在中期停止,随后发生细胞死亡。此外,灾难发生前的中期停滞被清楚地证明是由于纺锤体检查点的激活造成的,而使用RNA干扰抑制检查点功能允许癌细胞逃避有丝分裂灾难。我们的研究结果表明,纺锤体检查点功能是用dna损伤抗肿瘤药物治疗的癌细胞诱导突变所必需的。我们推测胶质母细胞瘤的化疗耐药可能是由于这些肿瘤的纺锤体检查点功能受损。
英文摘要
Cell cycle checkpoints prevent transition from one phase of the cell cycle to the next until all processes of the present phase are completed. Defects in the checkpoint functions result in gene mutations and chromosome damages, which contribute to the development and progression of tumors. However, loss of checkpoint function in some cancer cells is considered to be associated with their sensitivity to antineoplastic treatments such as chemotherapy and radiation. Most cancer cells including malignant gliomas are deficient in G_1 checkpoint function and therefore fail to arrest in G_1 phase on exposure to genotoxic agents. Instead, they accumulate temporarily in G_2 phase. However, given that the G_2 checkpoint is also partially impaired in cancer cells, they are unable to maintain G_2 arrest and eventually die as they enter mitosis. This process is known as mitotic catastrophe. The induction of mitotic catastrophe is an important goal of cancer therapies. In the present project, we characterized the dynamics of mitotic catastrophe induced by DNA damage in p53-deficient cancer cells. Most cells entering mitosis with DNA damage arrested at metaphase and subsequently underwent cell death. Furthermore, metaphase arrest prior to the catastrophe was clearly shown to result from activation of the spindle checkpoint, and inhibition of checkpoint function using RNA interference allowed cancer cells to escape mitotic catastrophe. Our findings suggest that the spindle checkpoint function is required for the induction of catastrophe in cancer cells treated with DNA-damaging antineoplastic agents. We speculate that chemoresistance of glioblastomas may be due to the impairment of spindle checkpoint function in those tumors.
期刊论文(64)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yasui Y, Urano T, Kawajiri A, Nagata KI, Tatsuka M, Saya H, Furukawa K, Takahashi T, Izawa I, Inagaki M: "Autophosphorylation of a newly identified site of Aurora-B is indispensable for cytokinesis."J Biol Chem. 279. 12997-13003 (2004)
Yasui Y、Urano T、Kawajiri A、Nagata KI、Tatsuka M、Saya H、Furukawa K、Takahashi T、Izawa I、Inagaki M:“Aurora-B 新确定位点的自磷酸化对于胞质分裂是必不可少的。”J Biol Chem
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Murakami, D., et al.: "Presenilin-dependent g-secretase activity mediates the intramembranous cleavage of CD44"Oncogene. (印刷中). (2003)
Murakami, D., et al.:“早老素依赖性 g-分泌酶活性介导 CD44 的膜内裂解”癌基因(2003 年出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hirota T, Kunitoku N, Sasayama T, Marumoto T, Zhang D, Nitta M, Hatakeyama K, Saya H: "Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells."Cell. 114. 585-598 (2003)
Hirota T、Kunitoku N、Sasayama T、Marumoto T、Zhang D、Nitta M、Hatakeyama K、Saya H:“Aurora-A 和相互作用的激活剂 LIM 蛋白 Ajuba 是人类细胞有丝分裂承诺所必需的。”细胞。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nagano O, Murakami D, Hartmann D, De Strooper B, Saftig P, Iwatsubo T, Nakajima M, Shinohara M, Saya H: "Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca^<2+> influx and
Nagano O、Murakami D、Hartmann D、De Strooper B、Saftig P、Iwatsubo T、Nakajima M、Shinohara M、Saya H:“通过 CD44 的细胞-基质相互作用是由响应细胞外 Ca^<2 激活的不同金属蛋白酶独立调节的
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Marumoto, et al.: "Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells"J Biol Chem. 278. 51786-51795 (2003)
Marumoto 等人:“Aurora-A 激酶维持 HeLa 细胞早期和晚期有丝分裂事件的保真度”J Biol Chem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 30 条
Development of anti-metastatic strategy based on analysis of premetastatic niche
-
批准号:23650601
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2011
-
负责人:SAYA Hideyuki
-
依托单位:
Development of new strategies to overcome glioblastoma invasiveness and drug-resistance using a glioma stem cell model
-
批准号:22249055
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.7万
-
财政年份:2010
-
负责人:SAYA Hideyuki
-
依托单位:
Research for development of novel therapeutic approaches targeting molecules regulating invasion and drug resistance of malignant gliomas
-
批准号:19209048
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$32.28万
-
财政年份:2007
-
负责人:SAYA Hideyuki
-
依托单位:
Identification of molecules regulating resistance and invasiveness of malignant gliomas and development of new therapeutic approaches
-
批准号:17209049
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$32.2万
-
财政年份:2005
-
负责人:SAYA Hideyuki
-
依托单位:
Analysis of role of mitotic regulation and its abnormalities in carcinogenesis
-
批准号:17013070
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$86.4万
-
财政年份:2005
-
负责人:SAYA Hideyuki
-
依托单位:
Basic analysis for development of inhibitors of malignant glioma invasion
-
批准号:12557119
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.38万
-
财政年份:2000
-
负责人:SAYA Hideyuki
-
依托单位:
Functional analysis of cell cycle regulators by in vitro gene targeting using DT40 cells
-
批准号:12470039
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.3万
-
财政年份:2000
-
负责人:SAYA Hideyuki
-
依托单位:
Identification of the novel genes which regulated differentiation of neuronal tissues and the diseases caused by their defects
-
批准号:10470296
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.13万
-
财政年份:1998
-
负责人:SAYA Hideyuki
-
依托单位:
Functional analysis of p53-induced apoptosis in glioma cells
-
批准号:08457369
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.61万
-
财政年份:1996
-
负责人:SAYA Hideyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
用一种新的方法研究Bub1调控有丝分裂的分子机制
-
批准号:31970666
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张刚
-
依托单位:
核酸酶LEM-3的生化性质与体内功能研究
-
批准号:31900509
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2019
-
负责人:洪烨
-
依托单位:
NK细胞抑制性受体CD96作为肝癌checkpoint免疫治疗靶点的进一步验证
-
批准号:81972679
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:孙昊昱
-
依托单位:
癌症和神经系统失调中的CENP-A泛素化的细胞器间信号通路
-
批准号:31970665
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:Yohei Niikura
-
依托单位:
信使RNA-m6A修饰对树突状细胞抗肿瘤免疫反应的调控机制研究
-
批准号:31870890
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:徐萌
-
依托单位:
免疫卡控点B7-H1、B7-H3和B7-H4病理检测试剂的研制及其在肠癌组织多重染色分析的临床意义
-
批准号:31700778
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2017
-
负责人:黄子逸
-
依托单位:
CXCR2+MDSCs亚群在PD1/PDL1阻断治疗乳腺癌无效或抵抗中的作用和机制研究
-
批准号:31770966
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2017
-
负责人:刘秋燕
-
依托单位:
SCAP/SREBP固醇代谢途径异常在胃癌PD-1hiCD8+耗竭性T细胞亚群形成中的作用机制及其逆转研究
-
批准号:31770963
-
项目类别:面上项目
-
资助金额:25.0万元
-
批准年份:2017
-
负责人:温倜
-
依托单位:
TRAF3IP3调控T细胞活性与肿瘤免疫的分子机制
-
批准号:31670896
-
项目类别:面上项目
-
资助金额:25.0万元
-
批准年份:2016
-
负责人:邹强
-
依托单位:
新型免疫抑制受体TIGIT介导NK细胞免疫耗竭及其逆转机制研究
-
批准号:31570893
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2015
-
负责人:孙汭
-
依托单位: